Home » Topics » Regulatory, BioWorld Science

Regulatory, BioWorld Science
RSS

FDA approves RPR's Nasacort for pediatric use

Oct. 20, 1997

Andrx's Diltia XT approved and launched in U.S.

Oct. 20, 1997

Shire files IND for new formulation of aciclovir

Oct. 20, 1997

Switch OTCs for allergies to be introduced by Fujisawa

Oct. 17, 1997

Fujisawa launches new OTC product

Oct. 17, 1997

Nascobal introduced in U.S., licensed to Meda for Nordic countries

Oct. 15, 1997

FDA actively reviewing TOBI

Oct. 13, 1997

CellPro seeks new indication for CEPRATE SC System

Oct. 13, 1997

Oral desmopressin evaluated in bed-wetting children

Oct. 13, 1997

Antiproliferative activity of simvastatin demonstrated against human gliomas

Oct. 13, 1997

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...